Mueller T, Thompson G K, Schröder R. "Method for the Synthesis of 2-Chloro-1-(1,2,5-oxadiazol-3-yl)ethanone" [P]. US Patent, US 10198300 B2, 2019-05-01.
发明人陈志强,冯建国,徐明华. "A Process for Preparing High-Purity 2-Chloro-1-(1,2,5-oxadiazol-3-yl)ethanone" [P]. 中国发明专利, 专利号 CN 110973663 B, 授权公告日 2025-01-22.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2019, 924, 8653-8678.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2017, 1849, (2), 2007-2011.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-1-(1,2,5-oxadiazol-3-yl)ethanone Using HRMS and NMR". Anal. Methods, 2025, 1167, (8), 3612-3625.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2019, 2073, (11), 1512-1537.